The relative toxicity of compounds used as preservatives in vaccines and biologics

Medical Science Monitor

Volumn 16, Issue 5, 2010, Pages

  Geier, David A ^a   Jordan, Sarah K ^b   Geier, Mark R ^b  

^a Department of Research   (United States)

^b Institute of Chronic Illnesses Inc   (United States)

Author keywords

Antimicrobial activity; Bacterial contamination; Preservatives; Toxicity

Indexed keywords

2 PHENOXYETHANOL; BENZETHONIUM CHLORIDE; PHENOL; THIOMERSAL; VACCINE; BIOLOGICAL PRODUCT; PRESERVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIUM CULTURE; COMPARATIVE TOXICOLOGY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NEUROBLASTOMA CELL; NONHUMAN; QUALITY CONTROL; UNITED STATES; CELL SURVIVAL; DRUG EFFECT; ESCHERICHIA COLI; TUMOR CELL LINE;

BIOLOGICAL PRODUCTS; CELL LINE, TUMOR; CELL SURVIVAL; ESCHERICHIA COLI; HUMANS; PRESERVATIVES, PHARMACEUTICAL; VACCINES;

EID: 77954254861     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ball LK, Ball R, Pratt RD: An assessment of Thimerosal use in childhood vaccines. Pediatrics, 2001; 107: 1147-54
2. Bernier RH, Frank JA, Nolan TF: Abscesses complicating DTP vaccination. Am J Dis Child, 1981; 135: 826-28
3. Simon PA, Chen RT, Elliot JA, Schwartz B: Outbreak of pyrogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccine. Pediatr Infect Dis J, 1993; 12: 368-71
4. Hekkens FEA, Polak-Vogelzang AA, Kreeftenberg JG: The antimicrobial effectiveness of some preservatives in inactivated human vaccines. J Biol Stand, 1983; 9: 277-85
5. Stetler HC, Garbe PL, Dwyer DM et al: Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccine. Pediatrics, 1985; 75: 299-303
6. Lowe I, Southern J: The antimicrobial activity of phenoxyethanol in vaccines. Lett Appl Microbiol, 1994; 18: 115-16
7. Geier DA, King PG, Geier MR: Mitochondrial dysfunction, impaired oxidative- reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to Thimerosal and other metal compounds. Toxicol Environ Chem, 2009; 91: 735-49
8. Geier DA, Sykes LK, Geier MR: A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J Toxicol Environ Health B Crit Rev, 2007; 10: 575-96
9. Salle AJ, Lazarus AS: A comparison of the resistance of bacteria and embryonic tissue to germicidal substances. Proc Soc Exp Biol Med, 1935; 32: 665-67
10. Welch H: Mechanism of the toxic action of germicides on whole blood measured by the loss of phagocytic activity of leucocytes. J Immunol, 1939; 37: 525-33
11. Welch H, Hunter AC: Method for determining the effect of chemical antisepsis on phagocytosis. Am J Public Health, 1940; 30: 129-37
12. Morton HE, North LL, Engley FB: The bacteriostatic and bactericidal actions of some mercurial compounds on Hemolytic streptococci: In vivo and in vitro studies. J Am Med Assoc, 1948; 136: 37-41
13. nd Mid-Year Meeting of the Chemical Specialties Manufacturer's Association, 1956
14. Byatt ME, Henderson A: Preoperative sterilization of the perineum: a comparison of six antiseptics. J Clin Pathol, 1973; 26: 921-24
15. Pinney RJ: Survival of plasmid-containing strains of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus in phenylmercuric nitrate and thiomersal. J Pharm Pharmacol, 1978; 30: 228-32
16. Porter FD, Silver S, Ong C, Nakahara H: Selection for mercurial resistance in hospital settings. Antimicrob Agents Chemother, 1982; 22: 852-58
17. Decicco BT, Lee EC, Sorrentino JV: Factors affecting survival of Pseudomonas cepacia in decongestant nasal sprays containing Thimerosal as preservative. J Pharm Sci, 1982; 71: 1231-34
18. Reader MJ, Lines CB: Decomposition of Thimerosal in aqueous solution and its determination by high-performance liquid chromatography. J Pharm Sci, 1983; 72: 1406-9
19. Blair AMJN, Clark B, Clarke AJ, Wood P: Tissue concentrations of mercury after chronic dosing of squirrel monkeys with thiomersal. Toxicology, 1975; 3: 171-76
20. Fagan DG, Pritchard JS, Clarkson TW, Greenwood MR: Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. Arch Dis Child, 1977; 52: 962-64
21. Burbacher TM, Shen DD, Liberato N et al: Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing Thimerosal. Environ Health Perspect, 2005; 113: 1015-21
22. Bührer C, Bahr S, Siebert J et al: Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation. J Hosp Infect, 2002; 51: 305-7
23. Kenyon EM, Seeley ME, Janszen D, Medinsky MA: Dose-, route-, and sexdependent urinary excretion of phenol metabolites in B6C3F1 mice. J Toxicol Environ Health, 1995; 44: 219-33
24. Fagundes A, Marzochi MC, Perez M et al: Skin reactivity to Thimerosal and phenol-preserved Montenegro antigen in Brazil. Acta Trop, 2007; 101: 25-30